PolarityTE Investor Relations Material
Latest events
Q2 2022
PolarityTE
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from PolarityTE Inc
Access all reports
PolarityTE, Inc., a clinical stage biotechnology company, develops and commercializes a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences in the United States. PolarityTE has developed unique capabilities for producing customized acellularized human tissues that it uses to manufacture and license a portfolio of products. Its ITR Technology Platform includes proprietary maintenance medium and home-use kits, as well as reagent kits to generate Acellular Human Osteochondral Tissue (AHOST) grafts from donor cartilage.
Latest articles
Puig's 2024 IPO: Paco Rabanne, Jean Paul Gaultier, and Beyond
Explore Puig's journey from its 1914 inception to a 2024 IPO, showcasing its growth, strategic acquisitions, and impact in the beauty and fashion industry.
15 Apr 2024
Alphabet's Unstoppable Rise: From Stanford to Global Tech Leader
Discover Alphabet's rise from a university project to a global tech leader, highlighting its growth, diversification, and visionary leadership.
15 Apr 2024
Companies That Had Their IPO in 2022: War, Inflation and Interest Rates
The stock market and IPO landscape in 2022 was marked by inflationary pressures, rate hikes, and war that heavily impacted the market sentiment.
15 Apr 2024
Ticker symbol
Country
🇺🇸 United States